Aktis Oncology, Inc. (AKTS)

Aktis Oncology Revenue

Aktis Oncology had revenue of $3.91M in the quarter ending September 30, 2026, with 147.31% growth. This brings the company's total for the last twelve months to $12.39M, up 122.77% year-over-year. In the year 2025, Aktis Oncology had annual revenue of $6.50M with 336.92% growth. That makes Aktis Oncology the 36,386th largest company in the world by revenue and 4,772nd in the United States.

• Revenue (ttm): $12.39M
• Revenue Growth: +122.77%
• P/S Ratio: 73.11
• Revenue / Employee: $156,785
• Employees: 79
• Market Cap: 905.49M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.50M	5.01M	336.92%
Dec 31, 2024	1.49M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Nov 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error